| human | Q5 |
| P227 | GND ID | 1029472629 |
| P2798 | Loop ID | 461495 |
| P496 | ORCID iD | 0000-0002-8316-7601 |
| P1153 | Scopus author ID | 57077739500 |
| P214 | VIAF ID | 294314444 |
| P10832 | WorldCat Entities ID | E39PBJt3WXjJvfbDcCbxQTxxDq |
| P108 | employer | University Hospital Leipzig | Q2496392 |
| P734 | family name | Schmidt | Q15240355 |
| Schmidt | Q15240355 | ||
| Schmidt | Q15240355 | ||
| P735 | given name | Frank | Q220546 |
| Frank | Q220546 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q48647232 | Agomelatine in breast milk. |
| Q46018363 | Applying EEG-based vigilance measurement in a case of adult attention deficit hyperactivity disorder. |
| Q30842926 | Brain arousal regulation as response predictor for antidepressant therapy in major depression. |
| Q48293225 | CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls |
| Q48347846 | Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls |
| Q49963795 | Cognitive behaviour therapy and inflammation: A systematic review of its relationship and the potential implications for the treatment of depression |
| Q45835598 | Correction: Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease. |
| Q48292772 | Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity |
| Q38154918 | Cytokines as biomarkers in depressive disorder: current standing and prospects. |
| Q47976154 | Dynamics of melanin-concentrating hormone (MCH) serum levels in major depressive disorder during antidepressant treatment |
| Q48310556 | Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease |
| Q48202410 | Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder |
| Q104068342 | Fatigue and brain arousal in patients with major depressive disorder |
| Q38908581 | Habenula volume increases with disease severity in unmedicated major depressive disorder as revealed by 7T MRI. |
| Q61814357 | Heart Rate Variability as Indicator of Clinical State in Depression |
| Q38915949 | Impact of Serum Cytokine Levels on EEG-Measured Arousal Regulation in Patients with Major Depressive Disorder and Healthy Controls |
| Q41673145 | Impact of lithium alone and in combination with antidepressants on cytokine production in vitro |
| Q37310533 | Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. |
| Q35187378 | Inflammatory cytokines in general and central obesity and modulating effects of physical activity |
| Q90773017 | Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy |
| Q38017259 | Neurobiology of depression and novel antidepressant drug targets. |
| Q39801480 | Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression. |
| Q59792260 | Serum Markers of Inflammation Mediate the Positive Association Between Neuroticism and Depression |
| Q48219182 | The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases. |
| Q86841477 | [Differential diagnosis of bipolar disorder: historical and clinical implications and perspectives] |
| Q84357369 | [Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression] |
Search more.